Korea
WuXi XDC and AbTis Sign Memorandum of Understanding for Development and Manufacturing of Antibody Drug Conjugates
SHANGHAI and SEOUL, South Korea, July 7, 2022 /PRNewswire/ -- WuXi XDC, a global leading CRDMO (Contract Research, Development and Manufacturing Organization) dedicated to end-to-end bioconjugates services, and AbTis, a Korean biotechnology company dedicated to the development of antibody drug c...
2022-07-08 09:27
4325
'#Me: 3D Avatar, Meet & Play' by Clover Games Releases Globally on Android and iOS
SEOUL, South Korea and SAN FRANCISCO, July 7, 2022 /PRNewswire/ -- On July 7th, 2022, an entertainment venture company, Clover Games, officially launched their virtual world service '#Me'" globally. '#Me' gathered more than 1.5 million pre-registrations around the world, showing the excitement an...
2022-07-07 15:00
2544
Ringle launches social impact programs in Korea and the United States
* Provides free one-on-one online English lessons for underprivileged college students * Donation for every new tutor hired in the US SEONGNAM, South Korea , July 6, 2022 /PRNewswire/ -- Ringle (co-CEOs Lee Sungpah and Lee Seunghoon), a company that provides one-on-one online English lessons ...
2022-07-06 21:00
1925
Cloocus recognized as the winner of the 2022 Microsoft Country Partner of the Year for the second consecutive year
SEOUL, South Korea, June 28, 2022 /PRNewswire/ -- Cloocus, a leading cloud experts group specialized in Microsoft, today announced it has won the Country of the Year 2022 Microsoft Partner of the Year Award. The company was honored among a global field of top Microsoft partners for demonstrating ...
2022-06-29 03:00
1684
MakinaRocks Unveils 'Link' - The AI Modeling Tool Built To Leap Technical Hurdles in JupyterLab
Link enhances the usability of JupyterLab, offering more readable pipelines and improved collaboration while eliminating Kubernetes' technological hurdles. SEOUL, South Korea, June 28, 2022 /PRNewswire/ -- MakinaRocks, an AI-based startup specializing in manufacturing and industrial solutions, to...
2022-06-28 21:00
1818
iNtRON to Seek a New Clinical Partner for SAL200 Endolysin
* TONABACASE, the first registered INN by WHO for Endolysin * First-in-Class Endolysin-based Drug against Superbugs * US FDA Phase 2 IND Approval for TONABACASE, SAL200 * Roivant has returned the rights for the asset just before the first patient injection BOSTON and SEOUL, South Korea, Jun...
2022-06-28 21:00
1710
CLAP successfully develops Retardation Film for OLED displays based on its own liquid crystal material technology
* Total solution from liquid crystal material design and synthesis to film manufacturing process technology * The Retardation Film is currently monopolized in the market * Expected to contribute greatly to the diversification of OLED display materials SEOUL, South Korea, June 28, 2022 /PRNew...
2022-06-28 20:00
1401
Reason why over ten legs are attached in Byeoru of Silla
GYEONGJU, South Korea, June 27, 2022 /PRNewswire/ -- The Gyeongju National Research Institute of Cultural Heritage(the GNRICH) announced a report on last 28th that provides evidence why there are more than 10 legs attached on Byeoru, excavated in Gyeongju Wolseong. Byeoru, a tool for writing a l...
2022-06-28 10:34
1420
Would people of Silla enjoy playing Go games with pebble stones?
GYEONGJU, South Korea, June 27, 2022 /PRNewswire/ -- The Gyeongju National Research Institute of Cultural Heritage(the GNRICH) released a report on the 28th that says people of Silla might have used Go games as means of diplomatic sports. On last 2020, a lot of pebble stones were excavated, whic...
2022-06-28 10:33
1342
Silla's cemetery, 'Jjoksaem', miniature of class society
GYEONGJU, South Korea, June 27, 2022 /PRNewswire/ -- On last 28, the Gyeongju National Research Institute of Cultural Heritage(the GNRICH) released a report that says there was distinction over social status related to Jjoksaem, the cemetery in Gyeongju Wolseong. The Jjoksaem excavation site, ce...
2022-06-28 10:33
1427
Daewoong Pharmaceutical begins multinational phase 2 clinical trial for DWN12088, a new drug for idiopathic pulmonary fibrosis
- U.S. Food and Drug Administration (FDA) approved the IND for the phase 2 clinical trial for patients with idiopathic pulmonary fibrosis - Daewoong Pharmaceutical to start a multinational phase 2 clinical trial for DWN12088 in September SEOUL, South Korea, June 24, 2022 /PRNewswire/ -- Daewoong...
2022-06-24 21:00
3588
"2022 Visit Korean Heritage Campaign" is ready to get rolling
This year's Campaign features ten tour courses, including a trip to "Cheongwaedae,"and selects Kim Min-ha as its official celebrity ambassador SEOUL, South Korea, June 21, 2022 /PRNewswire/ -- The 2022 Visit Korean Heritage Campaign, a joint project implemented jointly by the Cultural Heritage ...
2022-06-21 21:00
1588
Prof. Cho, head of the lung cancer center at Yonsei Cancer Hospital, "J INTS BIO's new oral administration 4th generation EGFR TKI 'JIN-A02' expected to be a game changer"
SEOUL, South Korea, June 21, 2022 /PRNewswire/ -- Prof. Cho Byoung-chul at Yonsei University College of Medicine (Director, Lung Cancer Center, Yonsei Cancer Hospital) is one of the most influential researchers in the lung cancer field and is involved in the development of innovative new drugs gl...
2022-06-21 17:00
1473
Sold Over 2 million Bottles Globally, Vegan Certified Sunscreen Line Became Another Steady Seller from d'Alba
SEOUL, South Korea, June 17, 2022 /PRNewswire/ -- d'Alba's waterfull sunscreens are their other signature line of products apart from the best-selling white truffle first spray serum. The steady selling sunscreen line includes three products with variations to accommodate different needs. The pro...
2022-06-17 21:00
4166
Lunit Files Registration Statement for Initial Public Offering
* First Korean healthcare company to obtain "AA-AA" ratings in technology assessment for its FDA-cleared and CE-marked solutions * To accelerate listing on the KOSDAQ market within July SEOUL, South Korea, June 16, 2022 /PRNewswire/ -- Lunit, a leading provider of AI solutions for cancer, tod...
2022-06-16 21:00
2526
J INTS BIO, Oral presentation of Preclinical results of its Novel Oral 4th Generation EGFR TKI 'JIN-A02' at the upcoming 2022 World Conference on Lung Cancer in Vienna, Austria
SEOUL, South Korea, June 14, 2022 /PRNewswire/ -- J INTS BIO announced that it
will be presenting the preclinical results of its NSCLC candidate 'JIN-A02' at
the upcoming 2022 IASLC World Conference on Lung Cancer, to be held inVienna,
Austria from 6th to 9th August.
2022-06-14 22:00
1088
Curocell announced impressive CR rate in Phase 1 study with anbal-cel, the next generation CD19 CAR-T integrated OVIS™ platform
- 82% ORR (9 of 11 patients) and 82% (9 of 11 patients) CR rate documented after anbal-cel treatment to the patients in relapsed/refractory large B-cell lymphoma - 2 out of 3 patients dosed with 2x105 cells/kg of anbal-cel lasting the complete response for more than 12 months - Well tolerat...
2022-06-13 19:00
1875
DSM and Firmenich confirm leadership team for proposed combined company DSM-Firmenich
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY (IN WHOLE OR IN PART) IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION. NOT FOR GENERAL RELEASE INTHE UNITED STATES – SEE FURTHER INFORMATION ...
2022-06-13 13:00
3883
LG Energy Solution Sets Up Special Advisory Council of Global Artificial Intelligence Experts
* New council established to drive company's digital innovation and promote manufacturing intelligence * Five global AI experts specializing in various crucial sectors assigned to spearhead key technological tasks SEOUL, South Korea, June 11, 2022 /PRNewswire/ -- LG Energy Solution (LGES; KRX...
2022-06-12 08:00
4051
J INTS BIO successfully held two Korean Advisory Board Meetings for its Novel Oral 4th Generation EGFR TKI (JIN-A02)
Members include the 10 leading NSCLC experts in Korea, discussing clinical design and R&D… SEOUL, South Korea, June 10, 2022 /PRNewswire/ -- J INTS BIO announced that it had conducted two Korean Advisory Board Meetings (ABM), first inDecember 2021 and the second in April this year for its novel ...
2022-06-10 17:00
1445
Week's Top Stories
Most Reposted
Rocket Travel by Agoda Shares Revealing New Report and Showcases Solution to Transform Hotel Distribution
[Picked up by 313 media titles]
2024-11-21 10:30Rockwell Automation and Microsoft Deliver on a Shared Vision to Accelerate Industrial Transformation
[Picked up by 308 media titles]
2024-11-20 13:29Durabook and Parent Company, Twinhead International Corp., Celebrate 40 Years of Innovation in Computing Solutions
[Picked up by 301 media titles]
2024-11-20 16:30
Travel loyalty programs to focus on offering personalized and flexible customer experiences in 2025
[Picked up by 298 media titles]
2024-11-19 10:42Philips and Edith Cowan University Australia Collaborate to Equip the Next Generation of Healthcare Professionals to leverage new technologies
[Picked up by 284 media titles]
2024-11-20 09:00
Most Read
Durabook and Parent Company, Twinhead International Corp., Celebrate 40 Years of Innovation in Computing Solutions
2024-11-20 16:30
5608
